Published in Scand J Infect Dis on January 01, 1994
Clinical microbiology of coryneform bacteria. Clin Microbiol Rev (1997) 8.40
Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection. Emerg Infect Dis (1997) 1.18
Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion. BMC Microbiol (2010) 0.89
Point-Counterpoint: A Nucleic Acid Amplification Test for Streptococcus pyogenes Should Replace Antigen Detection and Culture for Detection of Bacterial Pharyngitis. J Clin Microbiol (2016) 0.86
Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet (1989) 3.33
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol (1992) 2.36
Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol (1976) 2.05
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Use of antiserum agar plates for serogrouping of meningococci. J Clin Pathol (1977) 1.74
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells. Eur J Immunol (1976) 1.65
Streptococcus mutans establishment and dental caries experience in children from 2 to 4 years old. Scand J Dent Res (1983) 1.41
The disc and plate dilution methods in determination of the sensitivity of Neisseria gonorrhoeae to penicillin G, ampicillin and doxycycline. Chemotherapy (1970) 1.41
Conditions for inducing T helper cells in vitro. Scand J Immunol (1975) 1.39
T cell responses to PPD in BCG-vaccinated children with insulin-dependent diabetes mellitus and controls. Acta Paediatr (1994) 1.39
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study. Scand J Infect Dis (1988) 1.24
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
A comparative investigation of the generation of specific T cell-helper function induced by Streptococcus mutans in monkeys and mice. J Immunol (1980) 1.21
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice. Infect Immun (1979) 1.15
ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab (2000) 1.14
Antigen--antibody complexes as blocking factors on the T lymphocyte surface. Soc Gen Physiol Ser (1974) 1.13
Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother (1987) 1.12
Effect of the number of primed cells on the production of IgM and IgG antibodies in an adoptive secondary response. Int Arch Allergy Appl Immunol (1968) 1.11
Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol (1977) 1.11
Biotypes of Arcanobacterium haemolyticum. J Clin Microbiol (1994) 1.06
Mezlocillin in the treatment of gonorrhoea. Br J Vener Dis (1979) 1.06
Structural characteristics of antigen-specific suppressor factors: definition of 'constant' region and 'variable' region determinants. Thymus (1979) 1.06
Blocking antigen-antibody complexes on the T-lymphocyte activation during in vitro incubation before adoptive transfer. Immunology (1975) 1.05
Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
Enrichment of antigen-specific helper and suppressor T cells. Nature (1976) 1.04
Spectinomycin hydrochloride in the treatment of uncomplicated gonorrhoea in males and females. Br J Vener Dis (1974) 1.03
The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother (1990) 1.01
The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis (1978) 1.00
Induction of human antigen-specific suppressor factors in vitro. Clin Exp Immunol (1981) 0.97
Alpha-mannosidase: a rapid test for identification of Arcanobacterium haemolyticum. J Clin Microbiol (1994) 0.96
Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob Agents Chemother (1992) 0.96
Antimicrobial activity of bupivacaine and morphine. Anesthesiology (1985) 0.96
Pneumococcal bacteraemia during a recent decade. J Infect (1992) 0.95
Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis (1995) 0.95
Adult murine T cells activated in vitro by alpha-fetoprotein and naturally occurring T cells in newborn mice: identity in function and cell surface differentiation antigens. Proc Natl Acad Sci U S A (1978) 0.93
Antimicrobial susceptibility of Arcanobacterium haemolyticum. Antimicrob Agents Chemother (1994) 0.92
The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol (1988) 0.92
Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum (1988) 0.92
Fleroxacin versus standard therapy in gonococcal urethritis. J Antimicrob Chemother (1988) 0.92
Antigen-binding T cells as helper cells. Separation of helper cells by immune rosette formation. J Exp Med (1975) 0.92
Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations. Clin Exp Immunol (1981) 0.91
Increased yields of pathogenic Yersinia enterocolitica strains by cold enrichment. Scand J Infect Dis (1994) 0.91
Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease. Hum Pathol (1999) 0.91
High frequency of septicaemia in an outbreak of Salmonella stanley infections. Scand J Infect Dis (1996) 0.90
Partial characterization of murine and monkey helper factor to a streptococcal antigen. Immunology (1980) 0.89
Binding of bacterial adhesins to rat glomerular mesangium in vivo. Kidney Int (1993) 0.89
Penetration of erythromycin stearate into maxillary sinus mucosa and secretion in chronic maxillary sinusitis. Acta Otolaryngol (1977) 0.89
Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group. Chemotherapy (1991) 0.88
A monoclonal antibody against antigen-specific helper factor augments T-cell help. Nature (1983) 0.88
The effect of carrier-primed cells on an adoptive anti-hapten response. Eur J Immunol (1971) 0.88
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections. Scand J Infect Dis (1985) 0.88
The incidence of Pku in Finland. Acta Paediatr Scand (1971) 0.87
Cells infiltrating human periapical inflammatory lesions. J Oral Pathol (1986) 0.87
Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin. Eur J Clin Microbiol Infect Dis (1992) 0.86
Treatment of acute bronchitis and pneumonia with cefaclor. Postgrad Med J (1979) 0.86
In vitro activity of antifungal azoles against Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1992) 0.86
Affinity and Ig classes of anti-hapten antibodies in carrier-preimmunized rats. Eur J Immunol (1973) 0.86
Control of methicillin-resistant Staphylococcus aureus outbreak involving several hospitals. J Hosp Infect (2004) 0.86
Blocking antigen-antibody complexes on the T-lymphocye surface identified with defined protein antigens. II. Lymphocyte activation during the in vitro response. Immunology (1975) 0.85
Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect (1997) 0.85
Antigen-specific helper factor reacts with antibodies to human beta 2 microglobulin. J Immunol (1981) 0.85
Sensitivity of gonococcal strains to penicillin G, ampicillin and doxycycline in a Finnish metropolitan material in 1971. Acta Derm Venereol (1973) 0.85
Specific T helper and suppressor cells and factors induced in vitro to the hapten NP. Ann Immunol (Paris) (1980) 0.84
Differences in HLA types in children with insulin-dependent diabetes diagnosed in 1960s, 1970s, and 1980s. Lancet (1988) 0.84
Prophylactic methenamine hippurate or nitrofurantoin in patients with an indwelling urinary catheter. Ann Clin Res (1981) 0.84
Short-term treatment of gonorrhoea with intramuscular and oral forms of trimethoprim-sulphamethoxazole. Br J Vener Dis (1979) 0.84
Prospective study of the etiology of diarrhea in adult outpatients and inpatients. Scand J Gastroenterol (1989) 0.84
Pharmacokinetics and transplacental passage of imipenem during pregnancy. Antimicrob Agents Chemother (1992) 0.84
Septicemia caused by Neisseria weaveri. Clin Infect Dis (1997) 0.84
T cell hybrids with T cell functions. Curr Top Microbiol Immunol (1978) 0.84
Treatment with azlocillin in complicated urinary tract infections. Arzneimittelforschung (1979) 0.83
Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis. Scand J Infect Dis Suppl (1983) 0.83
Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus. Clin Exp Immunol (1992) 0.83
Immunochemical properties of antigen-specific monkey T-cell suppressor factor induced with a Streptococcus mutans antigen. Infect Immun (1980) 0.83
Definition of function-related isotypic markers on T cells. Curr Top Microbiol Immunol (1982) 0.83
Effect of number of haptens per carrier molecule on an adoptive secondary anti-hapten response. Int Arch Allergy Appl Immunol (1971) 0.83
T-cell hybridomas producing hapten-specific suppressor factors. Immunology (1981) 0.82
Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later. Immunobiology (1990) 0.82
Role of aeromonas isolated from feces of Finnish patients. Scand J Infect Dis (1995) 0.82
Hypothyroidism and anti-endothelial cell antibodies. APMIS (1993) 0.82
HLA-antigens and immunity to insulin in insulin-dependent diabetics with or without diabetic neuropathy. Scand J Clin Lab Invest (1988) 0.82
Human T-cell responses in vitro: cell interactions and factors. Ann N Y Acad Sci (1979) 0.82